Byrne Asset Management’s AbbVie ABBV Stock Holding History

Byrne Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$462K	Sell	1,836 -14	-0.8%	-$3.01K	0.25%	78
2026 Q1	$402K	Sell	1,850 -7	-0.4%	-$1.55K	0.24%	82
2025 Q4	$424K	Sell	1,857 -55	-3%	-$12.5K	0.23%	86
2025 Q3	$443K	Buy	+1,912	New	+$389K	0.27%	76
2025 Q2	–	Hold	0	–	–	–	80
2025 Q1	–	Hold	0	–	–	–	73
2024 Q4	–	Sell	-2,210	Closed	-$406K	–	72
2024 Q3	$436K	Buy	+2,210	New	+$412K	0.3%	76
2024 Q2	–	Hold	0	–	–	–	81
2024 Q1	–	Sell	-2,643	Closed	-$456K	–	73
2023 Q4	$409K	Buy	+2,643	New	+$385K	0.31%	78
2023 Q3	–	Sell	-2,869	Closed	-$421K	–	70
2023 Q2	$387K	Buy	2,869 +210	+8%	+$30.8K	0.25%	104
2023 Q1	$424K	Buy	2,659 +140	+6%	+$21.4K	0.3%	93
2022 Q4	$407K	Sell	2,519 -625	-20%	-$95.8K	0.29%	91
2022 Q3	$422K	Buy	3,144 +61	+2%	+$8.75K	0.33%	89
2022 Q2	$472K	Buy	3,083 +25	+0.8%	+$3.82K	0.35%	74
2022 Q1	$496K	Buy	3,058 +545	+22%	+$79.2K	0.31%	76
2021 Q4	$340K	Buy	+2,513	New	+$297K	0.22%	89

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Byrne Asset Management's ABBV Position: Q2 2026 in Review

Byrne Asset Management reduced its AbbVie (ABBV) stake by 0.76% in Q2 2026, selling an estimated $3.01K and leaving 1,836 shares worth $462K. The position accounts for 0.25% of the portfolio, ranked #78.

Byrne Asset Management first reported a position in ABBV in Q4 2021 and has held it in 13 quarters since. The position peaked at $496K in Q1 2022. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Byrne Asset Management held 1,836 shares of AbbVie worth $462K as of Q2 2026.
Byrne Asset Management sold 14 AbbVie shares in Q2 2026, an estimated $3.01K.
AbbVie made up 0.25% of Byrne Asset Management's portfolio in Q2 2026, its #78 holding.
Byrne Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 13 quarters since.
Byrne Asset Management's AbbVie position peaked at $496K in Q1 2022.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.